Risk of Candida Infection and Serious Infections in Patients with Moderate-to-Severe Psoriasis Receiving Biologics: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Figure 3

Forest plot of pooled data regarding Candida infections between anti-interleukin (IL)-17 agents and anti-IL-12/23 agents. CI, confidence interval.